165 related articles for article (PubMed ID: 15202494)
1. Trypanothione reductase activity is prominent in metacyclic promastigotes and axenic amastigotes of Leishmania amazonesis. Evaluation of its potential as a therapeutic target.
Castro-Pinto DB; Echevarria A; Genestra MS; Cysne-Finkelstein L; Leon LL
J Enzyme Inhib Med Chem; 2004 Feb; 19(1):57-63. PubMed ID: 15202494
[TBL] [Abstract][Full Text] [Related]
2. Antileishmanial activity and trypanothione reductase effects of terpenes from the Amazonian species Croton cajucara Benth (Euphorbiaceae).
Lima GS; Castro-Pinto DB; Machado GC; Maciel MA; Echevarria A
Phytomedicine; 2015 Nov; 22(12):1133-7. PubMed ID: 26547537
[TBL] [Abstract][Full Text] [Related]
3. Effect of amidine derivatives on nitric oxide production by Leishmania amazonensis promastigotes and axenic amastigotes.
Genestra M; Echevarria A; Cysne-Finkelstein L; Vignólio-Alves L; Leon LL
Nitric Oxide; 2003 Feb; 8(1):1-6. PubMed ID: 12586535
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase A of Leishmania amazonensis as a potential target for methoxy-amidine.
Genestra M; Echevarria A; Cysne-Finkelstein L; Leon LL
Arzneimittelforschung; 2001 Nov; 51(11):920-3. PubMed ID: 11765595
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of a new series of 3,5-disubstituted isoxazoles active against Trypanosoma cruzi and Leishmania amazonensis.
da Rosa R; de Moraes MH; Zimmermann LA; Schenkel EP; Steindel M; Bernardes LSC
Eur J Med Chem; 2017 Mar; 128():25-35. PubMed ID: 28152426
[TBL] [Abstract][Full Text] [Related]
6. Identification of chalcone-based antileishmanial agents targeting trypanothione reductase.
Ortalli M; Ilari A; Colotti G; De Ionna I; Battista T; Bisi A; Gobbi S; Rampa A; Di Martino RMC; Gentilomi GA; Varani S; Belluti F
Eur J Med Chem; 2018 May; 152():527-541. PubMed ID: 29758517
[TBL] [Abstract][Full Text] [Related]
7. The potential effects of new synthetic drugs against Leishmania amazonensis and Trypanosoma cruzi.
Canto-Cavalheiro MM; Echevarria A; Araujo CA; Bravo MF; Santos LH; Jansen AM; Leon LL
Microbios; 1997; 90(362):51-60. PubMed ID: 9301071
[TBL] [Abstract][Full Text] [Related]
8.
Matadamas-Martínez F; Hernández-Campos A; Téllez-Valencia A; Vázquez-Raygoza A; Comparán-Alarcón S; Yépez-Mulia L; Castillo R
Molecules; 2019 Sep; 24(18):. PubMed ID: 31487860
[TBL] [Abstract][Full Text] [Related]
9. Leishmania amazonensis trypanothione reductase: evaluation of the effect of glutathione analogs on parasite growth, infectivity and enzyme activity.
Castro-Pinto DB; Lima EL; Cunha AS; Genestra M; De Léo RM; Monteiro F; Leon LL
J Enzyme Inhib Med Chem; 2007 Feb; 22(1):71-5. PubMed ID: 17373550
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation against Leishmania amazonensis of novel pyrazolo[3,4-d]pyridazinone-N-acylhydrazone-(bi)thiophene hybrids.
Jacomini AP; Silva MJV; Silva RGM; Gonçalves DS; Volpato H; Basso EA; Paula FR; Nakamura CV; Sarragiotto MH; Rosa FA
Eur J Med Chem; 2016 Nov; 124():340-349. PubMed ID: 27597410
[TBL] [Abstract][Full Text] [Related]
11. In vitro evaluation of (-)α-bisabolol as a promising agent against Leishmania amazonensis.
Rottini MM; Amaral AC; Ferreira JL; Silva JR; Taniwaki NN; Souza Cda S; d'Escoffier LN; Almeida-Souza F; Hardoim Dde J; Gonçalves da Costa SC; Calabrese Kda S
Exp Parasitol; 2015 Jan; 148():66-72. PubMed ID: 25448354
[TBL] [Abstract][Full Text] [Related]
12. In vitro evaluation of 4-phenyl-5-(4'-X-phenyl)-1,3,4-thiadiazolium-2-phenylaminide chlorides and 3[N-4'-X-phenyl]-1,2,3-oxadiazolium-5-olate derivatives on nitric oxide synthase and arginase activities of Leishmania amazonensis.
Soares-Bezerra RJ; Leon LL; Echevarria A; Reis CM; Gomes-Silva L; Agostinho CG; Fernandes RA; Canto-Cavalheiro MM; Genestra MS
Exp Parasitol; 2013 Sep; 135(1):50-4. PubMed ID: 23693031
[TBL] [Abstract][Full Text] [Related]
13. An effective diaryl derivative against Leishmania amazonensis and its influence on the parasite X macrophage interaction.
Alves LV; Cysne-Finkelstein L; Temporal RM; Genestra MS; Leon LL
J Enzyme Inhib Med Chem; 2004 Oct; 19(5):437-9. PubMed ID: 15648659
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.
Tavares GSV; Mendonça DVC; Lage DP; Antinarelli LMR; Soyer TG; Senna AJS; Matos GF; Dias DS; Ribeiro PAF; Batista JPT; Poletto JM; Brandão GC; Chávez-Fumagalli MA; Pereira GR; Coimbra ES; Coelho EAF
Acta Trop; 2019 Mar; 191():29-37. PubMed ID: 30586571
[TBL] [Abstract][Full Text] [Related]
15. Structure-guided approach to identify a novel class of anti-leishmaniasis diaryl sulfide compounds targeting the trypanothione metabolism.
Colotti G; Saccoliti F; Gramiccia M; Di Muccio T; Prakash J; Yadav S; Dubey VK; Vistoli G; Battista T; Mocci S; Fiorillo A; Bibi A; Madia VN; Messore A; Costi R; Di Santo R; Ilari A
Amino Acids; 2020 Feb; 52(2):247-259. PubMed ID: 31037461
[TBL] [Abstract][Full Text] [Related]
16. Effects of amidine derivatives on parasite-macrophage interaction and evaluation of toxicity.
Temporal RM; Cysne-Finkelstein L; Echevarria A; de Souza MA; Sertà M; da Silva-Gonçalves AJ; Pirmez C; Leon LL
Arzneimittelforschung; 2002; 52(6):489-93. PubMed ID: 12109051
[TBL] [Abstract][Full Text] [Related]
17. Antileishmanial Activity, Cytotoxicity and Mechanism of Action of Clioquinol Against Leishmania infantum and Leishmania amazonensis Species.
Tavares GSV; Mendonça DVC; Lage DP; Granato JDT; Ottoni FM; Ludolf F; Chávez-Fumagalli MA; Duarte MC; Tavares CAP; Alves RJ; Coimbra ES; Coelho EAF
Basic Clin Pharmacol Toxicol; 2018 Sep; 123(3):236-246. PubMed ID: 29481714
[TBL] [Abstract][Full Text] [Related]
18. Amidine derivatives and Leishmania amazonensis: an evaluation of the effect of nitric oxide (NO) production on the parasite-macrophage interaction.
Temporal RM; Cysne-Finkelstein L; Echevarria A; Silva-Gonçalves AJ; Leon LL; Genestra MS
J Enzyme Inhib Med Chem; 2005 Feb; 20(1):13-8. PubMed ID: 15895679
[TBL] [Abstract][Full Text] [Related]
19. Metal-based compounds as prospective antileishmanial agents: inhibition of trypanothione reductase by selected gold complexes.
Colotti G; Ilari A; Fiorillo A; Baiocco P; Cinellu MA; Maiore L; Scaletti F; Gabbiani C; Messori L
ChemMedChem; 2013 Oct; 8(10):1634-7. PubMed ID: 24039168
[TBL] [Abstract][Full Text] [Related]
20. Privileged structure-guided synthesis of quinazoline derivatives as inhibitors of trypanothione reductase.
Cavalli A; Lizzi F; Bongarzone S; Brun R; Luise Krauth-Siegel R; Bolognesi ML
Bioorg Med Chem Lett; 2009 Jun; 19(11):3031-5. PubMed ID: 19414258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
